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Toll-like receptor 7 (TLR7) triggers antiviral immune
responses by recognizing viral single-stranded RNA
in endosomes, but the biosynthetic pathway of hu-
man TLR7 (hTLR7) remains unclear. Here, we show
that hTLR7 is proteolytically processed and that the
C-terminal fragment selectively accumulates in en-
docytic compartments. hTLR7 processing occurred
at neutral pH and was dependent on furin-like pro-
protein convertases (PCs). Furthermore, TLR7 pro-
cessing was required for its functional response
to TLR7 agonists such as R837 or influenza virus.
Notably, proinflammatory and differentiation stimuli
increased the expression of furin-like PCs in immune
cells, suggesting a positive feedback mechanism for
TLR7 processing during infection. Because self-RNA
can under certain conditions activate TLR7 and
trigger autoimmunity, our results identify furin-like
PCs as a possible target to attenuate TLR7-depen-
dent autoimmunity and other immune pathologies.
INTRODUCTION
Toll-like receptors (TLRs) have emerged as major regulators
of innate and adaptive immune responses to infection. Many
TLRs recognize products of microbial biosynthesis pathways,
which are absent in mammals, allowing for qualitative discrimi-
nation between microbial and host cells (Akira et al., 2006). In
contrast, TLR7 and TLR8 respond to viral and bacterial single-
stranded (ss) RNA and TLR9 to DNA which, barring small differ-
ences, are effectively invariant between host and pathogen. This
raises the issue of how TLRs 7, 8, and 9 can successfully discrim-
inate self from nonself. The nucleic acid-recognizing TLRs do not
respond to their ligands at the cell surface but in endosomes
(Blasius and Beutler, 2010; Kagan, 2012). This has led to the
notion that discrimination is achieved on the basis of ligand local-ization and that responses to self nucleic acids are avoided in
part through the absence of the latter from endosomal compart-
ments (Blasius and Beutler, 2010; Kagan, 2012). Consistent with
that notion, TLR7 and TLR9 can respond to self-RNA or -DNA,
respectively, if the latter are deliberately introduced into the
endocytic pathway (Diebold et al., 2004, 2006; Heil et al., 2004;
Leadbetter et al., 2002). This process may occur naturally in
some instances and contribute to autoimmunity in genetically
susceptible individuals (Krug, 2008; Shlomchik, 2009).
Newly synthesized TLR7, TLR8, and TLR9 translocate into the
endoplasmic reticulum (ER), from which they traffic to endo-
somes with help of the associated protein Unc93B1 (Brinkmann
et al., 2007; Kim et al., 2008; Lee et al., 2013). A possible expla-
nation as to why nucleic acid-recognizing TLRs respond to their
ligands only within endosomal compartments has come from
the observation that they undergo proteolytic cleavage in endo-
somes and that this cleavage is necessary for receptor activity
(Ewald et al., 2011; Lee et al., 2013; Park et al., 2008; Sepulveda
et al., 2009). Low pH-dependent endosomal cathepsins, as
well as asparaginyl endopeptidase (AEP), process mouse TLR9
(mTLR9) and these proteases might constitute attractive targets
for inhibition in cases of TLR-driven autoimmunity or patholog-
ical inflammation (Ewald et al., 2011; Park et al., 2008; Sepulveda
et al., 2009). mTLR7 is also cleaved by AEP (Maschalidi et al.,
2012). However, inhibition of cathepsins or AEP does not
completely prevent mouse TLR processing (Ewald et al., 2008;
Sepulveda et al., 2009), indicating involvement of additional pro-
teases. In addition, although human TLR9 (hTLR9) has also been
suggested to be cleaved by AEP (Sepulveda et al., 2009), most
analysis of TLR processing has been carried out with the mouse
receptors. Thus, there is a need to establish whether all TLRs are
processed similarly, whether this is true for human as well as
mouse receptors, and what other proteases might be involved
in cleavage.
The furin-like proprotein convertases (PCs) are a family of pro-
teases involved in processing of many polypeptides (Seidah
et al., 2008), including Notch, viral glycoproteins, growth factors
and their receptors, neuropeptides, metalloproteases, adhesion
molecules, enzymes, and even toxins (Hallenberger et al., 1992;
Logeat et al., 1998; Molloy et al., 1992; Rousselet et al., 2011b;Immunity 39, 711–721, October 17, 2013 ª2013 Elsevier Inc. 711
Immunity
Furin-like Proprotein Convertases Process Human TLR7Zarkik et al., 1997). Furin-like PCs encompass a family of nine
calcium-dependent serine endoproteases of the subtilisin-kexin
type called PC1/3, PC2, Furin, PC4, PC5/6, PACE4, PC7, SKI-1/
S1P, and PCSK9 (Seidah et al., 2008). The first seven enzymes
cleave their substrates after the C-terminal residue at sites
bearing the consensus motif matching the consensus K/RxnK/
R, where x indicates any amino acid residue, K/R designates a
lysine or an arginine residue, and n is 0, 2, 4, or 6 (Seidah
et al., 2008). PCs are synthesized as inactive proenzymes and
the inhibitory prosegment is removed through an initial autocat-
alytic processing event in the ER (all but PC2) or in immature
secretory granules (PC2) (Fuge`re et al., 2002; Seidah et al.,
2008). The heterodimer complex, consisting of the inhibitory pro-
segment and the rest of themolecule, then traffics from the ER to
specific subcellular compartments where catalytic activity is
acquired, usually after a second autocatalytic cleavage of the
prosegment that results in its release from the active enzyme
(Seidah et al., 2008). PC1/3 and PC2 are restricted to dense
core secretory granules of secretory cells whereas PC4 is found
primarily in testicular and ovarian tissues. In contrast, furin,
PACE4, PC5/6A, PC5/6B, and PC7 are ubiquitously expressed
in multiple cell types and located throughout the secretory
pathway (Fuge`re et al., 2002; Seidah et al., 2008). Notably,
furin-like PCs can be active at neutral pH (Decroly et al., 1996;
Malfait et al., 2008; Molloy et al., 1992) and generally cleave their
substrates in the trans-Golgi network (TGN), elsewhere along the
secretory pathway, or at the cell surface (Rousselet et al., 2011a;
Seidah et al., 2008). Rarely, cleavage can also occur in early
biosynthetic compartments such as the ER in cases where the
substrate outcompetes the inhibitory prosegment of the conver-
tase (Salvas et al., 2005). Their broad expression pattern, cleav-
age specificity, ability to act in endosomes, and localization
along the secretory pathway suggest that some furin-like PCs
could potentially contribute to TLR processing.
In this study, we show that hTLR7 undergoes proteolytic
processing and that the C-terminal fragment of the receptor
selectively accumulates in endocytic compartments. hTLR7 pro-
cessing was independent of low pH and largely independent of
cathepsin activity. Instead, hTLR7 processing was dependent
on the action of furin-like PCs. Our data underscore the notion
that endosomal TLRs are regulated by proteolysis and indicate
that this can occur at neutral pH, possibly in early endosomes
or in a pre-endosomal compartment, such as the ER, Golgi,
or plasma membrane. These results have implications for our
understanding of self/nonself nucleic acid discrimination and
highlight furin-like PCs as a possible target in attenuation of
TLR7-dependent autoimmunity and other immune pathologies.
RESULTS
Processing of Human TLR7 Generates a Truncated
C-Terminal Fragment that Accumulates in Phagosomes
To determine whether hTLR7 undergoes posttranslational pro-
teolytic processing, we tagged hTLR7 with a hemagglutinin
(HA) epitope at the carboxyl (C) terminus (TLR7-HA) and stably
expressed it in THP-1 (THP-TLR7), HEK293null (293null-TLR7),
and LoVo (LoVo-TLR7) cell lines. Immunoblot analysis with
anti-HA revealed a prominent band corresponding to the ex-
pected150 kD polypeptide, which was absent from green fluo-712 Immunity 39, 711–721, October 17, 2013 ª2013 Elsevier Inc.rescence protein (GFP)-expressing controls (Figure 1A). Notably,
anti-HA additionally detected a fainter band at around 75 kD in
TLR7-HA-expressing cells, but not in GFP-expressing controls
(Figure 1A). We confirmed that the 75 kD polypeptide corre-
sponds to a C-terminal fragment of TLR7 by immunoprecipita-
tion from lysates of THP-TLR7 followed by SDS-PAGE and
mass spectrometry analysis of the excised band (Figure 1B). Fig-
ure 1C shows the protein sequence of hTLR7 with the peptides
detected bymass spectrometry highlighted in black. All peptides
mapped C-terminal of a region encompassing residues 455–493
(Figure 1C, blue). This region is thought to form a flexible loop
between the leucine-rich repeats (LRR) 14 and 15 (Bell et al.,
2003) and its exposure might therefore make it a suitable target
for proteolytic enzymes.
Pretreatment of THP-TLR7 cells with PMA to induce differ-
entiation into macrophage-like cells, or with proinflammatory
cytokines such as IFN-g or IFN-a, led to an increase in total
detectable amount of TLR7 (Figures S1A and S1B available on-
line and data not shown). The same treatments also increased
the ratio of truncated 75 kDa to full-length 150 kDa TLR7 (Figures
2A, 2B, S1A, and S1B) and potentiated the ability of THP-TLR7
cells to produce IL-8, IL-6, and TNF-a in response to the specific
TLR7 agonist R837 (Figures 2A and 2B and data not shown).
Increased detection of truncated TLR7 was also seen after treat-
ment with the TLR4 agonist LPS (Figure 2C). Similarly, pretreat-
ment of primary human B cells with PMA, B cell receptor
crosslinking ± CD40L, IFN-a, or IFN-g also enhanced their ability
to respond to R837, as measured by cell surface staining for
CD83 (Figure S1C and data not shown). Thus, exposure of cells
to differentiation-inducing or proinflammatory cytokines in-
creases the amount of truncated TLR7 in total cell lysates and/
or responsiveness to TLR7 agonists.
We investigated whether truncated TLR7 might correspond to
a signaling-competent form of the receptor that localizes selec-
tively to the endocytic pathway in which ligand is encountered.
Consistent with that notion, phagosome preparations isolated
from R837-stimulated THP-TLR7 that had been fed latex beads
contained almost exclusively truncated TLR7 (Figure 2D). This
was in contrast to cell lysates, which contained the usual ratio
of truncated and total receptor (Figure 2D). As expected, phag-
osome preparations were positive for the lysosomal protein
LAMP1 but devoid of the ER marker calnexin (Figure 2D).
Cleaved TLR7 was detected in phagosomes isolated as early
as 15 min after latex bead incubation and cleavage was
unaffected by the addition of R837 (Figures S1D and S1E). We
conclude that hTLR7, like mTLR9 (Ewald et al., 2008) and
mTLR7 (Maschalidi et al., 2012), undergoes N-terminal process-
ing to generate a C-terminal fragment that selectively accumu-
lates in endocytic compartments.
Human TLR7 Processing Is Independent of Low pH
Processing of mTLR7 and mTLR9 mediated by cathepsins of
the cysteine protease family and/or AEP is strictly dependent
on endosomal acidification (Ewald et al., 2008; Park et al.,
2008; Sepulveda et al., 2009). We examined the effect of raising
endosomal pH in THP-TLR7 cells that had been pretreated with
PMA to increase generation of truncated receptor (see above).
The ratio of truncated to total TLR7 in total cell lysates, as
well as the appearance of truncated TLR7 in phagosomes,
Figure 1. A Truncated C-Terminal Fragment of TLR7 Is Present in Different Human Cell Lines
(A) HA-tagged proteins from THP-, 293null-, or LoVo-TLR7 cell lysates were analyzed by immunoblot with anti-HA. Representative of more than three inde-
pendent experiments. Full-length and truncated TLR7 are shown by filled and open arrowheads, respectively.
(B) Comparison of immunoblot and silver staining of proteins immunoprecipitated with anti-HA from THP-TLR7 or THP-GFP treated with PMA for 24 hr. Box
indicates polypeptides analyzed by nano LC-ESIMS/MS tandem mass spectrometry. MS analysis was performed once.
(C) Top: hTLR7 sequence, with peptides identified by MS analysis highlighted in black. The undefined region predicted by Bell et al. (2003) is shown in blue.
Potential furin-like PC recognition sites are underlined. Arginine and lysine residues within those sites are shown in red. Bottom: Alignment of the potential PC
recognition sites close to the undefined region within the hTLR7 and mTLR7 sequences.
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Furin-like Proprotein Convertases Process Human TLR7was unaffected by bafilomycin A, an inhibitor of the vacuolar H+-
ATPase, or monensin, a monovalent ionophore that dissipates
proton gradients (Figure 3A). As a positive control, the same
drug treatments blocked the conversion of pro-cathepsin (Cat)
B into mature enzyme and the trafficking of mature CatB into
phagosomes, as detected by probing cell lysates and phagoso-
mal fractions, respectively (Figure 3A). However, the block in
acidification prevented IL-8 production by PMA-treated THP-
TLR7 cells in response to R837 without affecting the viability
of the cells or their response to LPS (Figure S2A). Furthermore,
when we used the broad-range cathepsin inhibitor E64 supple-
mented with inhibitors specific for CatS and CatK, we did not
see inhibition of either TLR7 processing or R837-elicited IL-8
production (Figures 3B and 3C). However, when we used
EST, a more cell-permeable version of E64, we saw accumula-
tion of full-length TLR7 alongside cleaved TLR7 in phagosomes
(Figure 3B). Nevertheless, EST was not sufficient to decreasethe functional response of THP-TLR7 cells to R837 (Figure 3C,
right). Thus, endosomal acidification and cathepsin-like activity
appear largely dispensable for processing of hTLR7 in THP-1
cells.
Calcium-Dependent Serine-Proteases of the Furin-like
PCs Mediate Processing of Human TLR7
To test the involvement of other proteases in TLR7 processing,
PMA-differentiated THP-TLR7 were treated with a range of in-
hibitors. To obviate possible toxicity and to control for specificity,
we first titrated all drugs to identify the maximum concentration
that did not cause cell death or prevent responses to LPS (Fig-
ure S2B and data not shown). The serine-protease inhibitor
AEBSF reduced the detection of truncated TLR7 in cell lysates
and decreased the response of THP-TLR7 to R837 but not to
LPSwhen compared to the DMSO control (Figure 4A). Similar re-
sults were obtained with a second serine protease inhibitor,Immunity 39, 711–721, October 17, 2013 ª2013 Elsevier Inc. 713
Figure 2. Proinflammatory Stimuli Enhance
TLR7 Processing and Responses to TLR7
Agonists
(A–C) Immunoblot analysis of cell lysates from
THP-TLR7 treated for 24 hr with 10 nM PMA,
200 U/ml IFN-g (A), 1,000 U/ml IFN-a (B), or LPS
(C). Intensity of truncated TLR7 band is expressed
as percentage of the truncated + full-length TLR7
bands. (A and B) THP-TLR7 were differentiated
with PMA, IFN-g, or IFN-a as above and then
stimulated with R837 for another 24 hr. Values are
mean ± SD of triplicates. ****p < 0.0001 versus
control by Student’s t test.
(D) Phagosomes were isolated from THP-TLR7 fed
with or without latex beads in the presence of
R837. Lysates of pregradient (Pre) controls or
phagosome (Phag) were analyzed by immunoblot.
Full-length and truncated TLR7 are shown by filled
and open arrowheads, respectively.
Representative of at least three independent
experiments. See also Figure S1.
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Furin-like Proprotein Convertases Process Human TLR7TPCK (data not shown). In addition, calcium depletion via EDTA
in combination with the calcium ionophore A23187 also reduced
cleavage of TLR7 and selectively impaired the response of THP-
TLR7 to R837 but not to LPS (Figure 4B). Taken together, these
results suggested the involvement of a calcium-dependent
serine protease in hTLR7 processing.
THP-1 cells contained mRNA for Furin, Pc1/3 (Pcsk1), Pace4,
Pc5/6 (Pcsk5/6), and Pc7 (Pcsk7), especially after PMA-induced
differentiation or treatment with proinflammatory cytokines (Fig-
ure S3A and data not shown). We confirmed by immunoblot
that PMA, LPS, and IFN-g induce the upregulation of furin protein
in THP-1 cells (Figure S3B). Therefore, we tested whether TLR7
processing in PMA-treated THP-TLR7 cells was affected by
DC1, a dicoumarol derivative that potently inhibits furin,
PACE4, PC5/6, and (to a lesser extent) PC7 (Komiyama et al.,
2009). Notably, DC1 treatment reduced the ratio of truncated to
total TLR7 in total lysates of THP-TLR7 cells, which correlated
with a decrease in the response to R837 but not to LPS (Fig-
ure 4C). The loss of TLR7 processing was more marked when
phagosomal fractions were examined: as shown in Figure 4D,
DC1 pretreatment led to a complete loss of truncated TLR7
from THP-TLR7 phagosomes, which instead now contained
full-length receptor. Similar results were obtained with DC2,
another dicoumarol derivative that preferentially inhibits PC7
but has an additional effect on furin, PACE4, and PC5/6 (data
not shown) (Komiyama et al., 2009).
LoVo cells do not produce functional furin (Takahashi et al.,
1993; Zarkik et al., 1997) but express mRNA for Pace4, Pc5/6,
and Pc7 (data not shown). Like THP-TLR7 cells, LoVo cells
expressing TLR7 (but not parental LoVo) were able to respond
to R848 (another TLR7 agonist; Figure 5B and data not shown).
Thus, our data suggest that other members of the furin-like PC
family can substitute for furin in promoting TLR7 cleavage. To
assess the role of PC5/6 and PC7 in TLR7 processing, we gener-
ated LoVo-TLR7 cells stably expressing the preprosegments of
Pc5/6 (ppPc5) and/orPc7 (ppPc7),whichactas specific inhibitors
of the respective mature PC (Figure 5A; Fuge`re et al., 2002; Nour
et al., 2003; Zhong et al., 1999). Expression of either ppPc5 or714 Immunity 39, 711–721, October 17, 2013 ª2013 Elsevier Inc.ppPc7 or (in particular) both preprosegments led to a marked
reduction in R848-induced IL-8 secretion (Figure 5B) and TLR7
processing (Figure 5C anddata not shown). Thus, both proteases
appear to process hTLR7. We then decreased Pc5, Pc7, or Furin
expression in THP-TLR7 by using shRNA lentiviral particles tar-
geting the respective proteases. Furin knockdown resulted in
marked inhibition of TLR7 processing and of IL-8 production in
response to R837 but not LPS (Figure 5D). This effect was seen
with five different individual shRNA constructs targeting different
regions ofFurin, used separately or in combination (Figure 5Dand
data not shown). Consistent with these data, we were able to
show furin in phagosomes of THP-1 cells (Figure S1E and data
not shown). Knockdown of Pc7, but not Pc5, also inhibited
TLR7 processing and R837 responsiveness to some degree
(data not shown). We conclude that furin-like PCs in THP-1 and
LoVo cells are necessary for processing of hTLR7.
Mutation of a Potential PC Recognition Site Reduces
Human TLR7 Processing and Signaling
The hTLR7 protein sequence contains a prominent cluster of five
putative PC cleavage sites between residues 467 and 480 within
the flexible loop between LRR 14 and 15 (Figures 1C and S4A).
To further examine the role of furin-like PCs in the processing
of full-length TLR7, we removed all of the predicted furin-like
PC recognition sites within the undefined region by replacing
arginine 467 and arginine 473 with alanines (TLR7-mut; Figures
5E and S4A). Normal amounts of the TLR7-mut were expressed
in PMA-differentiated THP-1 cells but the fraction of truncated
protein was reduced (Figure 5F). This correlated with a lower
response to R837 when compared to cells bearing wild-type
TLR7 (Figure 5F), whereas the response to LPS was unaffected
(Figure S4B). TLR7-mut was able to traffic to late endosomes
and the extent of colocalization with the endosomal marker
Lamp1 was similar for TLR7 and TLR7-mut (Figures S4C and
S4D). We conclude that abrogation of putative furin-like PC
cleavage sites in the flexible loop between LRRs 14 and 15
impairs processing of hTLR7 and decreases generation of a
signaling-competent TLR7.
Figure 3. Inhibition of Acidification Does
Not Affect the Generation of Truncated
TLR7 and Its Accumulation in Phagosomes
(A) Immunoblot analysis of lysates of pregradient
controls (Pre) or phagosome (Phag) fractions pro-
bed with antibodies with the indicated specificity.
PMA-differentiated THP-TLR7 cells were treated
with indicated inhibitors for 12 hr before feeding
with latex beads in the presence of inhibitors and
R837 for 6 hr.
(B) PMA-differentiated THP-TLR7 were treated
with indicated inhibitors (E64 [20 mM], CatS [2 nM],
CatK [1.5 mM], EST [20 mM]) or carrier (ethanol;
EtOH) for 24 hr. Phagosomes were isolated and
analyzed as described above.
Full-length and truncated TLR7 are shown by filled
and open arrowheads, respectively. Asterisk (*)
indicates immature pro-CatB and hatch sign (#)
indicates mature CatB.
(C) PMA-differentiated THP-TLR7 cells were
treated with the indicated inhibitors for 24 hr and
then stimulated with R837 or LPS in the presence
of inhibitors for another 24 hr. IL-8 accumulation in
culture supernatants was measured by ELISA.
Values are mean ± SD of triplicates. ns indicates
nonsignificant versus control by Student’s t test.
Representative of at least three independent ex-
periments. See also Figure S2.
Immunity
Furin-like Proprotein Convertases Process Human TLR7The C-Terminal Portion of Human TLR7 Is Signaling
Competent
To verify the truncation site identified by site-directed mutagen-
esis and mass spectrometry analysis of the cleaved C-terminal
fragment, we made HA-tagged hTLR7 C-terminal fragments
(Cterm) of different lengths, starting after the different possible
cleavage sites within the undefined region (Figure S5A). The
construct CtermK starts at amino acid 481 and ends at position
1049 and therefore is similar to the C-terminal fragment of
mTLR7, ranging from residue 480 to 1052, that is functionally
active in cells overexpressing Unc93B1 (Maschalidi et al.,
2012). We expressed all constructs in THP-1 cells (THP-Cterm)
and carried out immunoblot analysis of PNGase F-treated cell
lysates to eliminate the confounding effects of glycosylation
(Figure S5B). The truncated version naturally found in cells
expressing wild-type TLR7 ran at an apparent molecular weight
between those of constructs CtermH to K (Figure S5B). There-
fore, hTLR7 processing occurs at one of the potential furin-like
PC recognition sites between amino acids 470 and 480.
Surprisingly, none of the C-terminal fragments rendered THP-
1 cells responsive to R837 (Figure 6A and data not shown). This
was not due to a lack of Unc93B1, because all transfectants ex-
pressed amounts of endogenous Unc93B1 (Figure S5C, top, and
data not shown) comparable to those in cell lysates of primaryImmunity 39, 711–721,peripheral blood mononuclear cells
(PBMCs), plasmacytoid dendritic cells
(pDCs), and B cells (Figure S5C, bottom).
Nevertheless, overexpression of C-termi-
nally FLAG-tagged Unc93B1 (Figure S5D)
did increase the IL-8 response of THP-
CtermK cells to R837 by around 10-fold(Figure 6A) and revealed the functional activity of the CtermK
fragment, albeit at lower activity than for full-length TLR7
(Figure 6A).
An explanation for the reduced ability of the TLR7 C-terminal
fragment to restore completely IL-8 response to R837 could be
that the TLR7 N-terminal fragment is required to ensure efficient
TLR7 trafficking into the endo-lysosomal compartment. Consis-
tent with that notion, the CtermK fragment was not detected in
phagosome fractions even though it could be easily detected
in the pregradient controls (Figure S5E). We hypothesized that
full-length TLR7 might be able to form a heterodimer with
CtermK and escort the latter to the endocytic pathway. To test
this hypothesis, THP-1 cells expressing the CtermK fragment
and the full-length TLR7 were tested for their ability to respond
to R837 in the presence or absence of DC1, which inhibits the
biological activity of full-length TLR7 but should not affect that
of the CtermK fragment. Consistent with this prediction, THP-1
cells coexpressing full-length TLR7 and the CtermK fragment
produced IL-8 in response to R837 and were resistant to DC1 in-
hibition (Figure S5F). In contrast, as before, DC1-treated THP-1
cells expressing full-length TLR7 alone failed to respond to
R837 stimulation (Figure S5F). Thus, expression of full-length
TLR7 partially restores the activity of CtermK fragment in trans.
Consistent with these findings, preliminary observations suggestOctober 17, 2013 ª2013 Elsevier Inc. 715
Figure 4. Calcium-Dependent Serine-Pro-
teases Mediate TLR7 Processing
(A–C) Immunoblot analysis of cell lysates of PMA-
differentiated THP-TLR7 treated with AEBSF
(0.25 mM) (A), EDTA (0.5 mM) + A23187 (0.5 mM)
(B), or DC1 (60 mM) (C) for 24 hr. Membranes were
probed with the indicated antibodies. Band in-
tensity is expressed as percentage of total TLR7.
For cytokine analysis, cells were treated as
described above and then stimulated with R837 or
LPS in the presence of inhibitors for another 24 hr
and IL-8 in culture supernatants was measured
by ELISA. Values are mean ± SD of triplicates. ns
indicates nonsignificant; *p < 0.05 versus control
by Student’s t test.
(D) Immunoblot analysis of lysates of pregradient
controls (Pre) or phagosome fractions (Phag) pro-
bed with antibodies specific for the indicated
proteins. PMA-differentiated THP-TLR7 cells were
treated with inhibitors 24 hr prior to incubation with
latex beads in the presence of R837.
Full-length and truncated TLR7 are shown by filled
and open arrowheads, respectively. Representa-
tive of at least three independent experiments. See
also Figure S3.
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partially restore the functional activity of the C-terminal fragment
(data not shown).
Finally, we extended these results by examining coupling to
the downstream signaling adaptorMyD88. Confocal microscopy
analysis showed that R837 stimulation enhanced colocalization
of MyD88 with TLR7 in THP-TLR7 cells treated with DMSO,
but not in cells treated with DC1 (Figures 6B and 6C). Because
phagosomes purified from untreated THP-TLR7 cells contain
only cleaved TLR7, whereas those purified from DC1-treated
cells contain the full-length TLR7 (Figures 2D and 4D), these
data indicate that MyD88 is specifically recruited in a ligand-
dependent manner to endosomes containing the TLR7 C-termi-
nal fragment but not full-length TLR7.
Furin-like PCs Are Required for TLR7Responsiveness in
Primary Human pDCs and B Cells
In humans, TLR7 expression is predominantly found on pDC and
B cells. We purified human pDCs from peripheral blood by pos-716 Immunity 39, 711–721, October 17, 2013 ª2013 Elsevier Inc.itive selection and cultured them with
DC1 inhibitor or with solvent alone
(DMSO). Unfortunately, the lack of anti-
bodies suitable for biochemical detection
of TLR7 prevented assessment of endog-
enous TLR7 cleavage in primary cells
(data not shown). Nevertheless, across
multiple experiments with cells from
different donors, we noticed that pDCs
preincubated with DC1 secreted mark-
edly less IFN-a in response to R837 or
heat-inactivated (56C for 30 min) influ-
enza virus (hiFlu), another TLR7 agonist
(Diebold et al., 2004), when compared to
DMSO-treated cells (Figure 7A). In addi-tion, cathepsin inhibitors had little effect on the response to hiFlu,
even though they decreased the response to R837 (Figure S6A).
We ruled out that lack of IFN-a was due to a toxic effect of the
inhibitors by monitoring cell viability (data not shown) and meta-
bolic activity (Figure S6B). As an additional source of cells ex-
pressing endogenous amounts of TLR7, we generated human
IFN-DCs from blood monocytes by differentiation in the pres-
ence of IFN-a and GM-CSF (Mohty et al., 2003). Treatment of
these cells with DC1, but not with DMSO, reduced their ability
to produce IL-8 in response to R837 but not to LPS (Figure 7B),
without affecting cell viability (data not shown). DC1 treatment of
B cells isolated from peripheral blood decreased IL-8 secretion
and upregulation of CD80 in response to R837 or hiFlu (Fig-
ure 7C). In contrast, the same response was not decreased
by EST (data not shown). Next, we assessed the effect of furin-
like PC inhibitors on the functional response to TLR9 agonists,
because the lack of suitable antibodies prevented direct assess-
ment of TLR9 cleavage. As shown in Figures 7D and 7E, DC1
markedly reduced CpG-induced activation of human pDCs
Figure 5. Furin, PC5/6, and PC7 Can
Mediate TLR7 Processing
(A–C) LoVo-TLR7 cells stably expressing IRES
control plasmid, or inhibitory preprosegments
ppPc7 or ppPc5, or ppPc7 and ppPc5 (ppPc5/7)
together.
(A) Semiquantitative RT-PCR showing expression
of preprosegments.
(B) IL-8 in supernatants of LoVo-TLR7 expressing
the indicated preprosegments and stimulated for
24 hr with R848.
(C) Immunoblots of cell lysates of LoVo-TLR7 ex-
pressing ppPc5 and ppPc7 and stained for HA.
Band intensity is expressed as percentage of
total TLR7.
(D) Immunoblot of cell lysates of THP-TLR7 ex-
pressing shRNA against furin or nontarget controls
stained for HA and furin (top). Band intensity is ex-
pressed aspercentage of total TLR7 (top right). IL-8
in supernatant of the samecells stimulated for 24 hr
with R837 (1 mg/ml) or LPS (0.1 mg/ml) (bottom).
(E) Schematic depiction of TLR7 and TLR7-mut.
The flexible loop is depicted in gray. Mutation
inserted within the flexible loop indicated by x.
(F) Cell lysates of PMA-differentiated THP-1 ex-
pressing indicated constructs were analyzed by
staining with anti-HA. IL-8 accumulation in culture
supernatants of indicated cell lines was monitored
by ELISA after 24 hr of stimulation with R837
(10 mg/ml).
All IL-8 histograms show mean ± SD (n = 3). ns
indicates nonsignificant; *p < 0.05; **p < 0.01 by
Student’s t test versus control. Full-length and
truncated TLR7 are shown by filled and open
arrowheads, respectively. Representative of either
two (A) or at least three (B–D, F) independent
experiments. See also Figure S4.
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pDCs in the same assay (Figure S6A, right). None of the inhibitors
was toxic to the cells (Figure S6B).
PMA treatment enhanced expression of furin protein in pDCs,
IFN-DCs, PBMCs, and B cells (Figure S6C). In pDCs furin was
also upregulated by IFN-a treatment (Figure S6C) and in B cells
by engagement of the B cell receptor, especially in combination
with CD40L (Figure S6C). Furthermore, B cell receptor crosslink-
ing, IFN-g, and IFN-a all increased Furin, Pc5, and Pc7 tran-
scripts in B cells (Figure S6D). We conclude that furin-like
PC activity is required to generate signaling-competent TLR7
in primary human cells and that expression of furin-like PCs is
increased in those cells by exposure to proinflammatory and
differentiation-inducing stimuli.
Finally, we assessed whether the role of furin-like PCs in TLR
processing might extend to mouse. The aligned mouse and
human TLR7 sequences showed (Figure 1C, bottom) furin-like
PC recognition sites at the exact same positions. DC1 treatment
reduced secretion of IL-12p40 by mouse macrophages inImmunity 39, 711–721,response to R837 and CpG but not LPS
(Figure S6E). However, consistent with
previously published data (Ewald et al.,
2008; Maschalidi et al., 2012), in mouse
macrophages cathepsin inhibition alsostrongly decreased responses to TLR7 and TLR9 agonists
(data not shown). Thus, furin-like PCs play a role in the process-
ing of TLRs across cell types and species, but other families of
proteases also contribute to differing degrees.
DISCUSSION
The recent finding that endosomal TLRs require processing by
low pH-dependent proteases has gained much attention as a
mechanism for reinforcing self/nonself nucleic acid discrimina-
tion. However, most studies supporting this concept have
been carried out with mTLR9 (Ewald et al., 2008; Park et al.,
2008; Sepulveda et al., 2009) or, more recently, mTLR7 (Mascha-
lidi et al., 2012) and have not been extended to human TLRs. In
this study, we show that hTLR7 is proteolytically cleaved in
different human immune and nonimmune cells and that receptor
processing is required for functional activity. Notably, TLR7
cleavage generates a C-terminal fragment that selectively accu-
mulates in compartments of the endocytic pathway and yet theOctober 17, 2013 ª2013 Elsevier Inc. 717
Figure 6. The Truncated Version of TLR7 Is Signaling Competent
(A) IL-8 secretion from THP-1 cells expressing the indicated constructs stimulated with R837 for 24 hr was measured by an ELISA. Values are mean ± SD (n = 3).
(B and C) THP-1 cells expressing HA-tagged TLR7 and FLAG-taggedMyD88 were PMA differentiated for 24 hr in the presence of DMSO or DC1 (70 mm) and then
stimulated for 3 hr with 5 mg/ml R837.
(B) Cells were then fixed and stained with anti-HA (shown in red) and anti-FLAG (shown in green). Confocal pictures were taken. Scale bars represent 5 mm (top
three rows) and 1 mm (bottom row).
(C) Li’s coefficient ofR10 cells per treatment was calculated to quantify the degree of colocalization of MyD88 and TLR7. Data obtained are represented as a box
and whisker plot. Whiskers show minimum to maximum of all the data.
Stats versus control (Student’s t test): **p < 0.01; ***p < 0.001. Representative of three independent experiments. See also Figure S5.
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compartments, making the involvement of acidic proteases un-
likely. Although our data do not fully rule out the involvement of
cathepsins, in particular ones that might be active at neutral
pH, we show that TLR7 processing requires calcium-dependent
serine proteases of the furin-like PC family and identify an impor-
tant site of furin-like PC cleavage within the loop between LRRs
14 and 15. These data extend to hTLR7 the processing paradigm
first established for mTLRs, but unexpectedly reveal that it can
occur independently of endosomal acidification and highlight
furin-like PCs as an important family of proteases in the regula-
tion of innate immune recognition.
Because acidification does not appear to be required for
hTLR7 cleavage, processing can occur before the receptor rea-
ches late endosomes, consistent with the fact that PCs can exert
catalytic activity throughout the biosynthetic pathway. Thus,
TLR7 cleavage might occur as early as the ER or Golgi before
diversion of the receptor to the endocytic pathway (Lee et al.,
2013). This early cleavage would ensure that a signaling-compe-
tent form of the receptor is already present in early endosomal
compartments with low cathepsin content where TLR7 signaling
has been reported to initiate (Honda et al., 2005a, 2005b; Sasai
et al., 2010). However, our data also suggest that the N terminus
of TLR7 helps direct the receptor to the appropriate endosomal
compartment, in which case its premature loss would be detri-718 Immunity 39, 711–721, October 17, 2013 ª2013 Elsevier Inc.mental. A recent study indicates that C- and N-terminal frag-
ments of mTLR7 can remain linked to each other via disulfide
bonds after cleavage (Kanno et al., 2013). Thus, early TLR7
cleavage by furin-like PCs need not preclude N-terminal-
directed trafficking to endosomes in the absence of disulfide
reduction. Although acidification was dispensable for cleavage,
it remained necessary for cellular responses to TLR7 agonists.
The question of why low pH is important for ligand recognition
and signaling by endosomal TLRs remains unresolved (Rutz
et al., 2004) but may be related to the protonation of specific
histidine residues at acidic pHs within the ligand binding domain
of TLRs (Govindaraj et al., 2011; Pirher et al., 2008). Another
possibility is that low pH-dependent thiol reductases facilitate
reduction of a putative disulfide link between the precleaved
N- and C-terminal fragments and release of the signaling-
competent TLR C-terminal fragment in the appropriate endoso-
mal compartment.
Several of our findings were obtained with transfected cells
overexpressing TLR7 in which some components of the TLR
biosynthetic pathway might be limiting. This was not the fact
for the more obvious player, Unc93B1 (Kim et al., 2008; Tabeta
et al., 2006), because overexpression in THP-TLR7 enhanced
the functional response to TLR7 agonists only slightly. Further-
more, we validated our results by using IFN-a differentiated
monocyte-derived DCs and human blood pDCs and B cells.
Figure 7. Pharmacological Inhibition of
Furin-like PCs in pDCs and B Cells Reduces
Responses to TLR7 and TLR9 Agonists
(A) Human pDC fractions were treated with DMSO
or DC1 (70 mM) for 24 hr and then stimulated with
R837 (1 mg/ml) or hiFlu (equivalent toMOIs of 0.5 or
1) overnight. IFN-a in supernatants was measured
by ELISA. Histograms show mean ± SD (n = 2).
(B) Human IFN-DCs were treated with DC1 (30 mm)
for 24 hr and then stimulated with R837 (2.5 or
5 mg/ml) or LPS (0.5 mg/ml) for 36 hr. Supernatants
were harvested and IL-8 content was measured.
Histograms show mean ± SD (n = 3).
(C) Human blood B cells were treated with DMSO
or DC1 (70 mM) for 24 hr and then stimulated with
R837 (10 mg/ml) or hiFlu (equivalent to MOI of 1.6)
for another 24 hr. IL-8 in supernatants was
measured by ELISA (left) and upregulation of CD80
was analyzed by FACS (right). Values are mean ±
SD of triplicates.
(D) Human pDC fractions were treated with DMSO
or DC1 (70 mM) for 24 hr, and then stimulated with
CpG-A (5 mg/ml) overnight. IFN-a secretion was
measured by ELISA. Values are mean ± SD of
duplicates.
(E) Human blood B cells were treated with DMSO
or DC1 (70 mM) for 24 hr and then stimulated with
anti-Fab alone or with anti-Fab ± CpG-B (5 mM) for
24 hr. Upregulation of cell surface expressed
CD80 was analyzed by flow cytometry.
ns indicates nonsignificant; *p < 0.05; **p < 0.01;
***p < 0.001 by Student’s t test versus control.
Representative of either at least three (A, B) or two
(C–E) independent experiments. See also Fig-
ure S6.
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functional response to agonists of TLR7 and also of TLR9,
arguing that our conclusions are generally applicable to TLR7
and, possibly, also to TLR9 regulation in primary human cells.
Whether they are also applicable to the other nucleic-acid-
sensing TLRs, such as TLR3 or TLR8, remains to be investigated.
We also found that treatment of human primary B cells or THP-
TLR7 cells with TLR7 agonists resulted in only a weak response,
which could be markedly potentiated by pretreating with proin-
flammatory and differentiation stimuli. Those stimuli greatly
increased the expression of furin-like PCs and enhanced TLR7
processing. Enhanced processing of TLR7 induced by inflam-
matory stimuli may therefore serve as a positive feedback
mechanism during infection. In contrast, in noninflammatory
situations, TLR7 processing might be limiting, contributing to
preventing TLR7 activation by self-RNA reaching endosomal-
lysosomal compartments.
Our preliminary studies suggest that furin-like PCs may also
play a role in generating functional mTLR7 and mTLR9 in mouse
macrophages. On the other hand, cathepsins and AEP clearly
have a dominant role in processing of mTLRs (Ewald et al.,
2008; Maschalidi et al., 2012; Park et al., 2008; SepulvedaImmunity 39, 711–721,et al., 2009). Such results suggest that
TLR7 cleavage may be differentially regu-
lated in human versus mouse, as well asin different cell types. Differential protease dependence may
also apply to different activation states of the same cell. Thus,
it may be possible to envisage strategies that selectively inhibit
TLR processing in specific cells by targeting different classes
of proteases. In this regard, derivatives of dicoumarol have
been extensively used in the clinic as anticoagulants and show
high bioavailability and relatively low toxicity (Alexander, 1962).
Our finding that furin-like PCs play an important role in TLR7 pro-
cessing in human pDCs suggests that selective inhibition of PCs
by dicoumarol derivatives could be useful as a therapeutic
approach for TLR7- and pDC-driven immune pathologies, such
as systemic lupus erythematosus.
EXPERIMENTAL PROCEDURES
More detailed description of reagents and experiments can be found in the
Supplemental Experimental Procedures.
Generation of IFN-DCs, and pDC and B Cell Isolation
Human IFN-DCs were generated by in vitro differentiation of the CD14+ sub-
population of PBMCs as described previously (Mohty et al., 2003). BDCA-4+
pDCs and CD19+ B cells were MACS sorted from leucocytes according to
the manufacturer’s instruction.October 17, 2013 ª2013 Elsevier Inc. 719
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Furin-like Proprotein Convertases Process Human TLR7DNA Cloning, Site-Directed Mutagenesis, Lentiviral Transduction,
and Gene Knockdown
hTlr7 tagged at the C terminus with HA was cloned into the lentiviral
vector pHR-SIN-IRES-Em (Demaison et al., 2002). Double mutations were
inserted with the quick QuikChange II XL Site-Directed Mutagenesis
Kit (Stratagene) according to the manufacturer’s conditions. MISSION
shRNA lentiviral vectors were from Sigma-Aldrich. Lentiviral vectors encod-
ing FLAG-tagged Unc93B1 or MyD88 were from GeneCopoeia. Cells trans-
duced with lentiviruses were selected by FACS sorting or puromycin
selection.
Cell Lysis and Quantitative Immunoblot Analysis
106 cells were lysed in 50 ml 1% (v/v) Triton X-100 based lysis buffer. Where
indicated, samples were digested with PNGAse F (NEB). Proteins were sepa-
rated by SDS-PAGE and standard immunoblot analysis was performed. To
calculate the percentage of truncated TLR7 per lane, the intensity of the
band of processed TLR7 was divided by the intensity of the band of total
TLR7 (shorter + longer fragment).
Large-Scale Immunoprecipitation and Tandem Mass Spectrometry
Lysate of PMA-differentiated THP-TLR7 cells was precleared with mouse IgG-
Agarose (Sigma) and immunoprecipitated with anti-HA-Agarose Clone HA-7
(Sigma). Eluted polypeptides were visualized by silver staining on SDS-
PAGE, and then tandem mass spectrometry was performed on bands of
interest.
IL-8, IFN-a, and mIL12-p40 Assay
Cells were stimulated for 24 hr with indicated TLR agonists. Conditioned me-
diumwas collected and secretion of hIL-8, hIFN-a, ormIL-12p40was analyzed
by enzyme-linked immunosorbent assay (ELISA).
Phagosome Isolation
Latex beads were fed to PMA-differentiated THP-1 cells, and cells were then
disrupted by dounce homogenization. Latex-bead-containing phagosomes
were isolated on a 60%–10% sucrose step gradient after ultracentrifugation.
Phagosomes were lysed in lysis buffer, and proteins were separated by
SDS-PAGE and visualized by immunoblot.
Transient Transfection and Antibiotic Selection
LoVo cells (70%–90% confluence) were transiently transfected by
mixing either 1 or 2 mg each of cDNAs of ppPC5 (Nie et al., 2003) or
ppPC7 (Zhong et al., 1999) with 6 ml FuGENE-6 as described by the manu-
facturer. After 12 hr, successfully transfected cells were selected by adding
G418.
Confocal Microscopy
PMA-differentiated THP-1 cells were fixed, permeabilized with 0.5% Triton
X-100, blocked, and then stained with primary followed by secondary anti-
bodies. Images were taken with a confocal microscope and Li’s coefficient
was calculated to measure the extend of colocalization.
Semiquantitative RT-PCR
Semiquantitative RT-PCR for amplification of ppPc5 and ppPc7 and forGapdh
as housekeeping gene was performed as described in the Supplemental
Experimental Procedures.
Statistics
All values are represented as the mean ± SD. An unpaired two-way Student’s
t test was performed to determine difference between the control and treated
group. Significance was accepted at p < 0.05 versus control. *p < 0.05; **p <
0.01; ***p < 0.001; ****p < 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2013.09.004.720 Immunity 39, 711–721, October 17, 2013 ª2013 Elsevier Inc.ACKNOWLEDGMENTS
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